109 related articles for article (PubMed ID: 19517869)
21. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
Shah NR; Shah A; Rather A
J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
[TBL] [Abstract][Full Text] [Related]
22. Images in emergency medicine: Acute severe coronary spasm associated with 5-fluorouracil chemotherapy.
Duran S; Bulur S; Sozen SB; Bilir C; Uyan C; Akdemir R
Emerg Med J; 2006 Jan; 23(1):85. PubMed ID: 16373818
[No Abstract] [Full Text] [Related]
23. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
24. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
[TBL] [Abstract][Full Text] [Related]
25. 5-Fluorouracil-induced coronary vasospasm.
Bathina JD; Yusuf SW
J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):281-4. PubMed ID: 19561527
[TBL] [Abstract][Full Text] [Related]
26. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
27. 5-fluorouracil-induced coronary vasospasm.
Shoemaker LK; Arora U; Rocha Lima CM
Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
[TBL] [Abstract][Full Text] [Related]
28. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
[TBL] [Abstract][Full Text] [Related]
29. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
30. Nursing considerations for capecitabine-based combination therapy.
Becze E
ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
[No Abstract] [Full Text] [Related]
31. A case of coronary spasm induced by 5-fluorouracil.
Gorgulu S; Celik S; Tezel T
Acta Cardiol; 2002 Oct; 57(5):381-3. PubMed ID: 12405579
[TBL] [Abstract][Full Text] [Related]
32. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
[No Abstract] [Full Text] [Related]
33. [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)].
Mallmann P; Nitschmann S
Internist (Berl); 2010 Jul; 51(7):923-4. PubMed ID: 20544172
[No Abstract] [Full Text] [Related]
34. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
35. [Breast cancer and the hand-foot syndrome].
Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
[TBL] [Abstract][Full Text] [Related]
36. Coronary vasospasm induced by cytostatic drugs: Kounis syndrome seems to be the most likely culprit.
Mazarakis A; Goudevenos J; Kounis NG
Hellenic J Cardiol; 2013; 54(6):482-5. PubMed ID: 24305588
[No Abstract] [Full Text] [Related]
37. 5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.
McGlinchey PG; Webb ST; Campbell NP
BMC Cardiovasc Disord; 2001; 1():3. PubMed ID: 11734065
[TBL] [Abstract][Full Text] [Related]
38. [Coronary vasospasm during 5-fluorouracil chemotherapy].
Sucker C; Scheffold N
Dtsch Med Wochenschr; 2001 Nov; 126(46):1300-1. PubMed ID: 11709733
[No Abstract] [Full Text] [Related]
39. Capecitabine induces severe angina-like chest pain.
Kuppens IE; Boot H; Beijnen JH; Schellens JH; Labadie J
Ann Intern Med; 2004 Mar; 140(6):494-5. PubMed ID: 15023730
[No Abstract] [Full Text] [Related]
40. [Tumor specific therapy. Targeted breast cancer therapy].
MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
